Latest Platform Security News

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

Stakk Limited defies the tech sector slowdown by securing nine new institutional clients in February, adding $1.67 million in annualised recurring revenue and reinforcing its AI-driven platform’s market traction.

Botanix Pharmaceuticals reports a surge in Sofdra sales driving revenue to $16.5 million, yet the company records a $33.2 million loss amid expanded marketing and operational costs. A $45 million capital raise aims to support growth and supply chain improvements.

Pathkey.AI has completed a strategic review, bolstered its leadership team, and secured $3.5 million in funding to accelerate growth and broaden its AI platform's applications beyond clinical trials.

Hiremii Limited has reported its highest-ever quarterly revenue and gross profit, driven by growth in its recruitment business and enhanced AI technology. The company also completed a significant capital raise to accelerate its expansion plans.

JAYRIDE Group Limited is advancing its transformation into a scalable Mobility-as-a-Service platform, securing new funding and expanding its SaaS footprint across the Asia-Pacific region.

Complii FinTech Solutions reported a 4.9% year-on-year increase in annual recurring revenue, progressed a major CRM system upgrade, and secured a $1.217 million R&D rebate in Q1 FY26, while managing cash flow pressures.

Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.

EV Resources has made significant strides in its antimony projects across Mexico and the US, securing a processing plant and planning a maiden drill program at Los Lirios, positioning itself for near-term production.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

IMEXHS Limited reported a $3 million net loss for the half-year ending June 2025, driven by a significant goodwill impairment, while annualised recurring revenue rose 11%. The company completed a $2.6 million capital raise to support growth amid ongoing cost optimisation and automation efforts.

FINEOS Corporation Holdings plc reported a 4.2% increase in revenue to €67.1 million for H1 2025, alongside a significant 76% reduction in losses, driven by subscription growth and operational efficiencies.